MARC details
000 -LEADER |
fixed length control field |
05740nam a22005655i 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
TR-AnTOB |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20231109085750.0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr nn 008mamaa |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
221129s2022 sz | s |||| 0|eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783031087745 |
024 7# - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.1007/978-3-031-08774-5 |
Source of number or code |
doi |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
TR-AnTOB |
Language of cataloging |
eng |
Description conventions |
rda |
Transcribing agency |
TR-AnTOB |
060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
WL 141.5.N47 |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MMP |
Source |
bicssc |
|
Subject category code |
MED056000 |
Source |
bisacsh |
|
Subject category code |
MKS |
Source |
thema |
096 ## - LOCALLY ASSIGNED NLM-TYPE CALL NUMBER (OCLC) |
Classification number |
WL141.5.N47EBK |
041 ## - LANGUAGE CODE |
Language code of text/sound track or separate title |
İngilizce |
245 10 - TITLE STATEMENT |
Title |
Neuroimaging Pharmacopoeia |
Medium |
[electronic resource] / |
Statement of responsibility, etc. |
edited by Daniel Thomas Ginat, Juan E. Small, Pamela Whitney Schaefer. |
250 ## - EDITION STATEMENT |
Edition statement |
2nd ed. 2022. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
Cham : |
Name of producer, publisher, distributor, manufacturer |
Springer International Publishing : |
-- |
Imprint: Springer, |
Date of production, publication, distribution, manufacture, or copyright notice |
2022. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 online resource |
336 ## - CONTENT TYPE |
Content type term |
text |
Content type code |
txt |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
computer |
Media type code |
c |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
online resource |
Carrier type code |
cr |
Source |
rdacarrier |
347 ## - DIGITAL FILE CHARACTERISTICS |
File type |
text file |
Encoding format |
PDF |
Source |
rda |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
PART I: Drugs and Alcohol -- 1. Tobacco -- 2. Alcohol -- 3. Methanol -- 4. Cannabis (Marijuana) -- 5. Synthetic Cannabinoids (spice/K2 preparations) -- 6. Crack and Cocaine -- 7. Amphetamines -- 8. Opioids -- 9. Betel Nuts -- 10. Licorice -- 11. Centella asiatica -- PART II: Contrast Agents -- 12. Iodinated Contrast Agents -- 13. Gadolinium-Based Contrast Agents -- 14. Ferumoxytol -- 15. Pantopaque (Myodil, Iodophenylundecylic Acid) -- 16. Thorium Dioxide (Thorotrast) -- PART III: Chemotherapy -- 17. Temozolamide (Temodar) -- 18. 1,3-Bis(2-Chloroethyl)-1-Nitrosourea (BCNU; Carmustine) Polymer Wafer (Gliadel) -- 19. Methotrexate -- 20. 5-Fluorouracil -- 21. L-Asparaginase (Elspar/Erwinase) -- 22. Calcineurin Inhibitors -- 23. Bromocriptine (Parlodel) and Cabergoline (Dostinex) -- 24. HiDAC (High-Dose Ara-C; Cytarabine; Cytosine Arabinoside; Cytosar-U; Depocyt) -- PART IV: Anti-cancer Immunotherapy -- 25. Ipilimumab (MDX-010, Yervoy) -- 26. Bevacizumab (Avastin) -- 27. Chimeric Antigen Receptor T-Cell Therapy (tisagenlecleucel and axicabtagene ciloleucel) -- PART V: Antiobiotics, Antiviral Agents, and Vaccines -- 28. Metronidazole (Flagyl) -- 29. Iodoform -- 30. Isoniazid -- 31. Highly Active Antiretroviral Therapy (HAART) -- 32. Vaccines -- PART VI: Antiepilectic, Antipsychotic, and General Anesthgetic Agents -- 33. Dilantin (Phenytoin Sodium) -- 34. Valproic Acid (Sodium Valproate, Depakote) -- 35. Vigabatrin (Sabril) -- 36. Lithium -- 37. Neuroleptics -- PART VII: Anesthetic and Sedative Agents -- 38. Barbiturates (Pentobarbital) -- 39. Nitrous Oxide (N2O) -- 40. Propofol -- PART VIII: Hemostatic and Vasoactive Agents -- 41. Embolic Agents -- 42. Aspirin and Plavix/Clopidogrel -- 43. Warfarin (Coumadin) -- 44. Heparin -- 45. Tissue Plasminogen Activator (tPA) -- 46. Oxidized Cellulose -- 47. Nasal Decongestants -- PART IX: Cardiovascular Support Agents -- 48. Supplemental Oxygen -- 49. Hypertonic Saline -- 50. Mannitol (1,2,3,4,5,6-Hexanehexol) -- 51. Triple H Therapy -- 52. Angiotensin Converting Enzyme (ACE) Inhibitors -- 53. Acetazolamide (Diamox) -- 54. Amiodarone -- PART X: Anti-inflammatory Agents -- 55. Acetominophen (Tylenol, Paracetamol) -- 56. Natalizumab (Tysabri, Biogen IDEC and Elan Pharmaceuticals) -- 57. Synthetic Corticosteroids -- PART XI: Dietary Supplements, Homeostatic Agents, Hormone-like Drugs -- 58. Manganese in Total Parenteral Nutrition -- 59. Zinc Oxide (ZnO) -- 60. Insulin -- 61. Bisphosphonates -- 62. Recombinant Human Bone Morphogenetic Protein -- 63. Retinoids (13-cis-Retinoic Acid, Isotretinoin, Accutane, All-trans-retinoic acid) -- 64. Topical Prostaglandin Analogues -- 65. Oral Contraceptives (Estrogen and Progestin) -- 66. Fish Oil -- PART XII: Injectable Filler Agents -- 67. Calcium hydroxyapatite-based Fillers -- 68. Hyaluronic Acid-based Fillers -- 69. Injectable Silicone Oil. |
520 ## - SUMMARY, ETC. |
Summary, etc. |
This book, now in a revised and updated second edition, reviews the imaging-relevant features of selected classes of pharmaceuticals and drugs regarding CNS and head and neck images. The agents discussed belong to classes like Drugs and Alcohol; Contrast Agents; Chemotherapy; Immunotherapy; Antibiotics, Antiviral Agents, and Vaccines; Antiepilectic and Antipsychotic Agents; and Hematologic Agents, each of which is addressed in a separate chapter. The book’s closing part addresses agents from various other classes. For each class, concise texts and rich images review and illustrate the mechanism of action. All chapters from the previous edition have been extensively updated, and new chapters on certain pharmaceuticals have been added. Highlighting the implications of these agents for imaging findings, the book offers an excellent resource for neuroradiologists and clinicians alike. . |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Radiology. |
|
Topical term or geographic name entry element |
Pharmacology. |
|
Topical term or geographic name entry element |
Radiology. |
|
Topical term or geographic name entry element |
Pharmacology. |
653 #0 - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Neuroimaging |
|
Uncontrolled term |
Brain -- drug effects |
|
Uncontrolled term |
Spinal Cord -- drug effects |
|
Uncontrolled term |
Drug-Related Side Effects and Adverse Reactions |
|
Uncontrolled term |
Substance-Related Disorders |
|
Uncontrolled term |
Tomography |
|
Uncontrolled term |
Diagnosis, Differential |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Ginat, Daniel Thomas. |
Relator term |
editor. |
Relator code |
edt |
-- |
http://id.loc.gov/vocabulary/relators/edt |
|
Personal name |
Small, Juan E. |
Relator term |
editor. |
Relator code |
edt |
-- |
http://id.loc.gov/vocabulary/relators/edt |
|
Personal name |
Schaefer, Pamela Whitney. |
Relator term |
editor. |
Relator code |
edt |
-- |
http://id.loc.gov/vocabulary/relators/edt |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
<a href="https://doi.org/10.1007/978-3-031-08774-5">https://doi.org/10.1007/978-3-031-08774-5</a> |
Materials specified |
Springer eBooks |
Public note |
Online access link to the resource |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
National Library of Medicine |
Koha item type |
E-Book |